Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|April 2, 2026
BRAF class II-III mutations in NSCLC: a single center experienceSara Torresan, Martina Bortolot, Elisa Bertoli, et al.
In Vivo (Athens, Greece)|August 19, 2021
Acquired EGFR C797G Mutation Detected by Liquid Biopsy as Resistance Mechanism After Treatment With Osimertinib: A Case ReportElisa DE Carlo, Monica Schiappacassi, Giacomo Pelizzari, et al.
Future Oncology (London, England)|April 8, 2026
Lorlatinib in patients with ALK-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV studyAlessandra Bearz, Serena Ricciardi, Nirmal Vivek Raut, et al.
Frontiers in Bioscience (Landmark Edition)|December 29, 2011
The role of diet in gastric cancer: still an open questionMassimiliano Berretta, Alessandro Cappellani, Arben Lleshi, et al.
Oncotargets and Therapy|December 22, 2018
Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case reportElisa De Carlo, Monica Schiappacassi, Martina Urbani, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2009
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung CancerAlessandra Bearz, Isabella Garassino, Marcello Tiseo, et al.
Oncology|September 28, 2021
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16)Umberto Basso, Giuseppe Procopio, Giuseppe Fornarini, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2013
Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-upEmilio Minatel, Marco Trovo, Jerry Polesel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive DiseaseSai-Hong I Ou, Benjamin J Solomon, Alice T Shaw, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancerMarco Trovo, Emilio Minatel, Elena Durofil, et al.
Pageof 12